Wockhardt tumbles owing to regulatory obstacle
DSIJ Intelligence / 08 Mar 2017
Wockhardt declined 3.57 per cent in early trade, and is trading at Rs 731.5 on an intraday basis. The stock is trading under pressure as Ireland’s health regulatory body has inspected its Aurangabad facility.
Wockhardt declined 3.57 per cent in early trade, and is trading at Rs 731.5 on an intraday basis. The stock is trading under pressure as Ireland’s health regulatory body has inspected its Aurangabad facility.
The Health Products Regulatory Authority of Ireland (HPRA) has inspected the Company's Shendra, Aurangabad facility. The regulatory authority has recommended the renewal of certificate based on the general compliance with the principles and guidelines of Goods Manufacturing Practices (GMPs).
On financial front, Wockhardt's revenue increased 7.35 per cent to Rs 996 crore in Q3FY17 as compared to same period in previous financial year. The company posted operating profit of Rs 18.12 crore in Q3FY17 against operating profit of Rs 71.75 crore in Q3FY16. It posted net loss of Rs 53.91 crore in Q3FY17 while net profit of Rs 72 crore in Q3FY16.
Going forward, the investors should watch, how Wockhardt will be able to fulfill the observatory requirements put forward by the regulatory body.
The stock price of Wockhardt has dropped almost 24 per cent in last one year.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.